Skip to main content
. 2023 Nov 11;16:81–93. doi: 10.2147/IBPC.S433907

Table 3.

Binary Logistic Regression Outputs for Factors Associated with Hypertension Among Patients Receiving ART in Public Hospitals in Harar City, Harar, Eastern Ethiopia, 2023 (n = 382)

Variables Hypertension Crude Odds Ratio (95% CI) p-value
Yes (%) No (%)
Sex
 Female 42 (47.7) 163 (55.4) Reference
 Male 46 (52.3) 131 (44.6) 1.36 (0.84, 2.20) 0.204
Age category (years)
 18–24 12 (13.6) 41 (13.9) Reference
 25–34 29 (32.9) 105 (35.7) 0.94 (0.44, 2.02) 0.882
 35–44 25 (28.4) 96 (32.7) 0.89 (0.41, 1.94) 0.769
 45–54 18 (20.5) 41 (13.9) 1.5 (0.64, 3.51) 0.349
 55 and above 4 (4.6) 11 (3.7) 1.24 (0.33, 4.62) 0.746
Marital status
 Single 24 (27.3) 96 (32.8) Reference
 Married 36 (40.9) 122 (41.6) 1.18 (0.66, 2.11) 0.576
 Divorced 11 (12.5) 36 (12.3) 1.22b(0.54, 2.75) 0.627
 Widowed 17 (19.3) 39 (13.3) 1.74 (0.85, 3.60) 0.132
Family income
 Low (less than 1500 ETB) 45 (51.1) 150 (51.0) Reference
 Low-middle (1500–3500) 30 (34.1) 95 (32.3) 1.05 (0.62, 1.79) 0.849
 Middle (3501–5000) 4 (4.6) 28 (9.5) 0.48 (0.16, 1.43) 0.186
 Middle-high (greater than 5000) 9 (10.2) 21 (7.1) 1.43 (0.61, 3.34) 0.410
Residence
 Urban 61 (69.3) 236 (80.3) Reference
 Rural 27 (30.7) 58 (19.7) 1.80 (1.05, 3.08) 0.032
Duration on HAART
 Less than 24 months 38 (43.2) 133 (45.2) Reference
 24 months and above 50 (56.8) 161 (54.8) 1.09 (0.67, 1.76) 0.734
HAART regimen change
 No 27 (30.7) 56 (19.1) Reference
 Yes 61 (69.3) 238 (80.9) 0.53 (0.31, 0.91) 0.021
Current HAART regimen*
 AZT/3TC/DTG 24 (27.3) 95 (32.3) Reference
 AZT/3TC/EFV 28 (31.8) 72 (24.5) 1.54 (0.82, 2.88) 0.176
 TDF/3TC/DTG 21 (23.9) 73 (24.8) 1.14 (0.53, 2.27) 0.700
 TDF/3TC/EFV 15 (17.0) 54 (18.4) 1.10 (0.53, 2.27) 0.798
Adherence to HAART
 No 28 (31.8) 70 (23.8) Reference
 Yes 60 (68.2) 224 (76.2) 0.67 (0.40, 1.13) 0.133
Family of history of NCDs**
 No 71 (80.7) 205 (69.7) Reference
 Yes 9 (10.2) 45 (15.3) 0.58 (0.27, 1.24) 0.159
 I do not know 8 (9.1) 44 (15.0) 0.52 (0.24, 1.17) 0.114
Recent viral load, copies/mL
 Less than 600 17 (19.3) 70 (23.8) Reference
 600–999 57 (64.8) 188 (63.9) 1.25 (0.68, 2.29) 0.474
 1000 and above 14 (15.9) 36 (12.2) 1.60 (0.71, 3.61) 0.257
Opportunistic infections
 No 41 (46.6) 176 (60.1) Reference
 Yes 47 (53.4) 117 (39.9) 1.72 (1.07, 2.79) 0.026
Body mass index, kg/m2
 Underweight (less than 18.5) 3 (3.4) 23 (7.8) Reference
 Normal (18.5–24.99) 37 (42.0) 168 (57.1) 1.69 (0.48, 5.92) 0.413
 Pre-obese (25–29.99) 24 (27.3) 65 (22.1) 2.83 (0.78, 10.29) 0.114
 Obese (30 and above) 24 (27.3) 38 (12.9) 4.84 (1.31, 17.89) 0.018
Physical activity
 Not Active 37 (42.0) 130 (44.2) Reference
 Active 51 (58.0) 164 (55.8) 1.09 (0.67, 1.77) 0.719
Tobacco smoking
 Do not smoke 81 (92.0) 271 (92.2) Reference
 Current smoker 3 (3.4) 18 (6.1) 0.56 (0.16, 1.94) 0.359
 Past smoker 4 (4.6) 5 (1.7) 2.68 (0.70, 10.2) 0.149

Notes: *Current HAART regimen; **NCDs: Non-Communicable Diseases.

Abbreviations: AZT, Zidovudine; 3TC, Lamivudine; DTG, Dolutegravir; EFV, Efavirenz; and TDF, Tenofovir.